Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient golimumab (ATC code according to WHO: L04AB06) -684421

World Biggest Tenders Source

This tender with title Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient golimumab (ATC code according to WHO: L04AB06) -684421 has been published on Bidding Source portal dated 15 Nov 2024 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Germany

Tender Title :

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient golimumab (ATC code according to WHO: L04AB06) -684421

Tender Type :

Invitation for Bids

Country :

Germany

Publish Date :

15 Nov 2024

Closing Date :

31 Dec 2025

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient tiotropium bromide (ATC code according to WHO: R03BB04) -684322 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient tocilizumab (ATC code according to WHO: L04AC07) -683491 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient brinzolamide/timolol (official ATC code: S01ED67) -683594 Germany Contract Manufacturing Organisation (CMO) - Remedi4all - PR798936-3640-I -685134 Germany Pharmaceutical discount agreements from 01.01.2025 for various active ingredients within the framework of an open-house procedure -683646 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient infliximab for subcutaneous injection (ATC code according to WHO: L04AB02) -684145 Germany Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient rotigotine (ATC code according to WHO: N04BC09) -684657 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products containing the active ingredient levothyroxine sodium (H03AA01) within the framework of a so-called open-house model. - 675443 Germany Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 SGB V for the active ingredients mentioned with the possibility of conclusion within the framework of the so-called open house procedure. - 683215 Germany Pharmaceutical products – Patent_80.2 - 681458 Germany

Conclusion of a non-exclusive drug discount agreement pursuant to Section 130a Paragraph 8 of the Social Code Book V by means of an open-house model for the active ingredient golimumab (ATC code according to WHO: L04AB06) -684421

General Information

Germany

Similar Tenders

Pharmaceutical products Tenders

Germany Tenders

Europe Tenders

Tenders

info@biddingsource.com